AdventHealth to study COVID-19 outcomes with AI biotech firm

by on

AdventHealth and biotechnology company Berg are creating a biobank of demographic and clinical data from COVID-19 cases, which they’ll use to study what interventions were linked with better patient outcomes.

AdventHealth and biotechnology company Berg are creating a biobank of demographic and clinical data from COVID-19 cases, which they’ll use to study what interventions were linked with better patient outcomes.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: